Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William D Shipe

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Bioorganic & Medicinal Chemistry Letters|November 9, 2017
The identification of a novel lead class for phosphodiesterase 2 inhibition by fragment-based drug designAshley B Forster, Pravien Abeywickrema, Jaime Bunda, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2015
Discovery of pyrazolopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophreniaIzzat T Raheem, John D Schreier, Joy Fuerst, et al.
Journal of Medicinal Chemistry|June 11, 2008
Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonistWilliam D Shipe, James C Barrow, Zhi-Qiang Yang, et al.
Journal of Medicinal Chemistry|September 27, 2008
Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channelsZhi-Qiang Yang, James C Barrow, William D Shipe, et al.
ACS Chemical Biology|August 31, 2022
A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected CellsKeith P Moore, Adam G Schwaid, Matthew Tudor, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding GroupChristopher J Bungard, Peter D Williams, Jeanine E Ballard, et al.
Journal of Medicinal Chemistry|February 16, 2024
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine MimicValerie W Shurtleff, Mark E Layton, Craig A Parish, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Bioorganic & Medicinal Chemistry Letters|November 9, 2017
The identification of a novel lead class for phosphodiesterase 2 inhibition by fragment-based drug designAshley B Forster, Pravien Abeywickrema, Jaime Bunda, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2015
Discovery of pyrazolopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophreniaIzzat T Raheem, John D Schreier, Joy Fuerst, et al.
Journal of Medicinal Chemistry|June 11, 2008
Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonistWilliam D Shipe, James C Barrow, Zhi-Qiang Yang, et al.
Journal of Medicinal Chemistry|September 27, 2008
Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channelsZhi-Qiang Yang, James C Barrow, William D Shipe, et al.
ACS Chemical Biology|August 31, 2022
A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected CellsKeith P Moore, Adam G Schwaid, Matthew Tudor, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding GroupChristopher J Bungard, Peter D Williams, Jeanine E Ballard, et al.
Journal of Medicinal Chemistry|February 16, 2024
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine MimicValerie W Shurtleff, Mark E Layton, Craig A Parish, et al.
Pageof 2